Form 8-K - Current report:
SEC Accession No. 0001641172-25-008761
Filing Date
2025-05-06
Accepted
2025-05-06 08:59:37
Documents
13
Period of Report
2025-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37373
  Complete submission text file 0001641172-25-008761.txt   210872

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hepa-20250430.xsd EX-101.SCH 3026
3 XBRL LABEL FILE hepa-20250430_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE hepa-20250430_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3704
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 25915567
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)